Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,084 public trials 6,466 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

NCT07223814

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • US-San Francisco CA-UCSF San Francisco, California, United States
  • US-Atlanta GA-EMORY Atlanta, Georgia, United States
  • US-Kansas City KS-KUMC Kansas City, Kansas, United States
  • US-Baltimore MD-UMGCCC Baltimore, Maryland, United States
View all 82 locations
View Trial Details
Recruiting

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

NCT06561347

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Colorado Blood Cancer Institute (CBCI) Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

NCT02582697

Conditions
Germ Cell Tumor, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations
  • Memorial Sloan Kettering Cancer Centre New York, United States
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Prince of Wales Hospital Sydney, New South Wales, Australia
View all 56 locations
View Trial Details

Related conditions